FibroGen Inc (NAS:FGEN)
$ 1.24 0.05 (4.2%) Market Cap: 123.35 Mil Enterprise Value: 90.73 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 56/100

Q4 2020 FibroGen Inc Earnings Call Transcript

Mar 01, 2021 / 10:00PM GMT
Release Date Price: $50.53 (+1.00%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the FibroGen Fourth Quarter and Full Year 2020 Financial Results Conference Call. (Operator Instructions). Please be advised for today's conference is being recorded. (Operator Instructions).

I would now like to hand the conference over to your speaker today, Mr. Michael Tung. Thank you, please go ahead.

Michael Tung
FibroGen, Inc. - IR Executive

Thank you, Lindon, and good afternoon, everyone. I'm Michael Tung, Vice President of Corporate Strategy and Investor Relations at FibroGen. Joining me on today's call are Enrique Conterno, our Chief Executive Officer; Dr. Percy Carter, our Chief Scientific Officer; Pat Cotroneo, our Chief Financial Officer; Dr. Mark Eisner, our Chief Medical Officer; Thane Wettig, our Chief Commercial Officer; Chris Chung, our Senior Vice President of China operations; and Dr. Elias Kouchakji, our Senior Vice President of Clinical Development, Drug Safety and Pharmacovigilance.

The format for today's call includes prepared remarks from Enrique and Pat,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot